The value of economic modeling studies in the evaluation of treatment strategies for multiple sclerosis

被引：9

作者：

Detournay, B ^{[1
]}

机构：

[1] Cemka Eval Team, Bourg La Reine, France

来源：

VALUE IN HEALTH | 2002年 / 5卷 / 01期

关键词：

D O I：

10.1046/j.1524-4733.2002.51001.x

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：1 / 2

页数：2

共 10 条

[1]

Auty A, 1998, CAN J NEUROL SCI, V25, P23

[2] INTERRATER AND INTRARATER SCORING AGREEMENT USING GRADES 1.0 TO 3.5 OF THE KURTZKE EXPANDED DISABILITY STATUS SCALE (EDSS) [J].

GOODKIN, DE ;

COOKFAIR, D ;

WENDE, K ;

BOURDETTE, D ;

PULLICINO, P ;

SCHEROKMAN, B ;

WHITHAM, R ;

JACOBS, L ;

MUNSCHAUER, F ;

EMRICH, L ;

GRANGER, C ;

HERNDON, R ;

RUDICK, R ;

FISCHER, J ;

SIMON, J ;

SALAZAR, A .

NEUROLOGY, 1992, 42 (04) :859-863

[3] The economic cost of multiple sclerosis in Sweden in 1994 [J].

Henriksson, F ;

Jonsson, B .

PHARMACOECONOMICS, 1998, 13 (05) :597-606

[4] Long term treatment of multiple sclerosis with interferon-β may be cost effective [J].

Kendrick, M ;

Johnson, KI .

PHARMACOECONOMICS, 2000, 18 (01) :45-53

[5] Cost-utility analysis of interferon beta-1b in secondary progressive multiple sclerosis [J].

Kobelt, G ;

Jönsson, L ;

Henriksson, F ;

Fredrikson, S ;

Jönsson, B .

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (03) :768-780

[6] Drug treatment of multiple sclerosis - Clinical review was unsystematic [J].

Milne, R ;

Clegg, A ;

Bryant, J .

BRITISH MEDICAL JOURNAL, 2001, 322 (7281) :299-299

[7] Economic evaluation of multiple sclerosis in the UK, Germany and France [J].

Murphy, N ;

Confavreux, C ;

Haas, J ;

Konig, N ;

Roullet, E ;

Sailer, M ;

Swash, M ;

Young, C ;

Merot, JL .

PHARMACOECONOMICS, 1998, 13 (05) :607-622

[8] Medical progress: Multiple sclerosis. [J].

Noseworthy, JH ;

Lucchinetti, C ;

Rodriguez, M ;

Weinshenker, BG .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :938-952

[9] Recommendations from the national multiple sclerosis society clinical outcomes assessment task force [J].

Rudick, R ;

Antel, J ;

Confavreux, C ;

Cutter, G ;

Ellison, G ;

Fischer, J ;

Lublin, F ;

Miller, A ;

Petkau, J ;

Rao, S ;

Reingold, S ;

Syndulko, K ;

Thompson, A ;

Wallenberg, J ;

Weinshenker, B ;

Willoughby, E .

ANNALS OF NEUROLOGY, 1997, 42 (03) :379-382

[10] A PURCHASER PERSPECTIVE OF MANAGING NEW DRUGS - INTERFERON-BETA AS A CASE-STUDY [J].

WALLEY, T ;

BARTON, S .

BRITISH MEDICAL JOURNAL, 1995, 311 (7008) :796-799

← 1 →